Cantor Equity Partners I, Inc. (NASDAQ:CEPO) announced the pricing of its $200 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “CEPO”, Tuesday, January 7, 2025.
The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on targets that have positive long-term growth prospects, competitive advantages and consolidation opportunities.
Cantor Equity Partners I’s sponsor team is led by Chairman and Chief Executive Officer Brandon Lutnick, and Chief Financial Officer Jane Novak. Danny H Salinas, Douglas Barnard and Robert Sharp will serve on its Board of Directors.
Total SPAC deal count for 2025 year-to-date is now 1. This offering is expected to close on Wednesday, January 8, 2025.
Cantor Fitzgerald & Co. is acting as the sole book running manager for the offering. Ellenoff, Grossman & Schole LLP is serving as Issuer’s Counsel with Graubard Miller LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Transfer & Trust Company is acting as trustee.
Berto Acquisition Corp. (NASDAQ:TACOU) announced the pricing of its upsized $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TACOU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target but will have a particular interest in artificial intelligence, wellness, longevity,...
Lakeshore Acquisition III Corp. (NASDAQ:LCCCU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LCCCU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target with a team that has previously closed business combinations in the...
Churchill Capital Corp X (NASDAQ:CCCXU) has filed for a $300 million SPAC with a broad search focus, to add to the portfolio of Churchill deals. Five Churchill deals have closed (I, II, III, IV, and AltC), while V, VI and VII liquidated in the SPAC downturn. However, keep in mind that the Churchill team still...
Black Hawk Acquisition Corp (NASDAQ:BKHA) has entered into a definitive agreement to combine with biotech firm Vesicor Therapeutics at a pre-money equity value of $70 million. San Gabriel, California-based Vesicor is developing treatments utilizing extracellular vesicles as both a therapy themselves and as a delivery system for other medicines. The combined company is expected to...
At the SPAC of Dawn SPAC activity has continued to heat up as the market now has a new business combination to digest alongside two new SPACs making their debut on the Nasdaq later today. Three more new SPACs have filed their initial S-1s to eventually join them. That makes 29 SPAC IPOs and 49...